References
1. Gordon Paul H. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging and Disease 2013;4(5):295–310.
2. Kim SH. Diagnosis and therapeutic strategies of amyotrophic lateral sclerosis. Hanyang Medical Reviews 2006;26(1):45–51.
3. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118(3):707–19.
4. Caroscio JT, Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis, its natural history. Neurol Clin 1987;5(1):1–9.
5. Mulder DW. Motor neuron disease. In : Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy 2nd ed. 2Philadelphia PA: WB Saunders; 1984. p. 1525–36.
6. Radunovic A, Annane D, Rafiq MK, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. The Cochrane Database of Systemic Reviews 2013;published online 28. :3.
7. Gordon PH, Corcia P, Lacomblez L, et al. Defining survival as an outcome measure in amyotrophic lateral sclerosis. Arch Neurol 2009;66(6):758–61.
8. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347(9013):1425–31.
9. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330(9):585–91.
10. Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease(MND). Cochrane Database Syst Rev 2012;published online 14. :3.
11. Gordon PH, Mitsumoto H. Chapter 20 symptomatic therapy and palliative aspects of clinical care. Handb Clin Neurol Netherlands: North-Holland Pub Co.; 2008. p. 389–424.
12. Heckmatt JZ, Loh L, Dubowitz V. Night-time nasal ventilation in neuromuscular disease. Lancet 1990;335(8689):579–82.
13. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5(2):140–7.
14. Lee S, Kim S. The effects of Sa-am acupuncture treatment on respiratory phsiology parameters in amyotrophic lateral sclerosis patients: a pilot study. Evid Based Complement alternat Med 2013. published online 11. p. 9.
15. Tandan R, Bradley WG. Amyotrophic lateral sclerosis: part 1. clinical features, pathology, and ethical issues in management. Ann Neurol 1985;18(3):271–80.
16. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344(22):1688–700.
17. Del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60(5):813–19.
18. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies(an evidencebased review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2009;73(24):1218–26.
19. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005;171(3):269–74.
20. Baumann F, Henderson RD, Morrison SC, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph lateral sclera 2010;(1–2):194–202.
21. Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH. The effect of non-invasive positive pressure ventilation(NIPPV) on cognitive function in amyotrophic lateral sclerosis(ALS): a prospective study. J Neurol Neurosurg Psychiatry 2001;71(4):482–7.
22. Heiman-Patterson TD, Miller RG. NIPPV: a treatment for ALS whose time has come. Neurology 2006;67(5):736–7.
23. Korean acupuncture & Moxibustion Medicine Society Textbook Compailation Commitee. Korean acupuncture & moxibustion medicine Ha volume Gyeonggi: Jipmoondang; 2008. p. 197–200.
24. Heo J. Donguibogam Seoul: Yeogang Publishing Company; 1994. p. 1060–1.
p. 1102–3.
25. Kim DH. Illustrations Kyokam Sa-am Do-in acupuncture Busan: Sogang; 2002. p. 475–80.
26. Wade OL. Movements of the thoracic cage and diaphragm in respiration. The Journal of physiology 1954;124(2):193.
27. Barrett Kim E, Barman Susan M, Boitano Scott, Brooks Heddwen. “35. Pulmonary Function”. Ganong's review of medical physiology 23rd editionth ed. USA: McGraw-Hill Companies, Incorporated; 2009. Cite uses deprecated parameters(587–638 help).
28. Campbell EJM. The role of the scalene and sternomastoid muscles in breathing in normal subjects. An electromyographic study. Journal of Anatomy 1955;89(3):378–86.
29. Netter FH. Atlas of human anatomy. 3rd edth ed. Icon learning systems Teterboro. New Jersey: Icon learning systems; 2003. p. 191.
30. Raper AJ, Thompson WT, Shapiro W, Patterson JL. Scalene and sternomastoid muscle function. Journal of Applied Physiology 1966;21(2):497–502.
31. De Troyer A. Respiratory muscle function. In : Gibson J, Geddes DM, Costabel U, eds. Respiratory medicine London: Saunders; 2003. p. 119–29.
32. Rakhit R, Cunningham P, Furtos-Matei A, et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 2002;277(49):47551–6.
33. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995;676(1):25–40.
34. Nguyen MD, Lariviere RC, Julien JP. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001;30(1):135–47.
35. MuDan Cai, Choi SM, Song BK, Son IH, Kim SC, Yang EJ. Scolopendra subspinipes mutilans attenuates neuroinflammation in symptomatic hSOD1G93A mice. Journal of Neuroinflammation 2013;10(1):131.
36. Lee SH, Choi SM, Yang EJ. Melittin ameliorates the inflammation of organs in an amyotrophic lateral sclerosis animal model. Exp Neurobiol 2014;Mar. 23(1):86–92.
37. Gammage GW, Banner MJ, Blanch PB, et al. Ventilator displayed tidal volume: what you see may not be what you get. Crit Care Med 1988;16(4):454.